share_log

Chimeric Therapeutics Ltd: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial

Jul 22 08:12
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.